JP2016508956A - 局所疼痛の治療のための組成物と治療法 - Google Patents

局所疼痛の治療のための組成物と治療法 Download PDF

Info

Publication number
JP2016508956A
JP2016508956A JP2015510898A JP2015510898A JP2016508956A JP 2016508956 A JP2016508956 A JP 2016508956A JP 2015510898 A JP2015510898 A JP 2015510898A JP 2015510898 A JP2015510898 A JP 2015510898A JP 2016508956 A JP2016508956 A JP 2016508956A
Authority
JP
Japan
Prior art keywords
pain
administration
composition
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015510898A
Other languages
English (en)
Japanese (ja)
Inventor
カンデュラ，マヘシュ
Original Assignee
セリックスビオ プライヴェート リミテッド
セリックスビオ プライヴェート リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セリックスビオ プライヴェート リミテッド, セリックスビオ プライヴェート リミテッド filed Critical セリックスビオ プライヴェート リミテッド
Publication of JP2016508956A publication Critical patent/JP2016508956A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
JP2015510898A 2012-05-10 2013-02-16 局所疼痛の治療のための組成物と治療法 Pending JP2016508956A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1843CH2012 2012-05-10
IN1843/CHE/2012 2012-05-10
PCT/IB2013/051268 WO2013168006A2 (en) 2012-05-10 2013-02-16 Compositions and methods for the treatment of local pain

Publications (1)

Publication Number Publication Date
JP2016508956A true JP2016508956A (ja) 2016-03-24

Family

ID=54193695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510898A Pending JP2016508956A (ja) 2012-05-10 2013-02-16 局所疼痛の治療のための組成物と治療法

Country Status (8)

Country Link
EP (1) EP2882745A2 (zh)
JP (1) JP2016508956A (zh)
CN (1) CN105612155A (zh)
AU (1) AU2013257727B2 (zh)
CA (1) CA2873138A1 (zh)
SG (1) SG11201407323WA (zh)
WO (1) WO2013168006A2 (zh)
ZA (1) ZA201408055B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021152048A (ja) * 2016-12-26 2021-09-30 セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited 慢性疼痛の処置のための組成物及び方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
AU2012362524B2 (en) 2011-12-30 2018-12-13 Relievant Medsystems, Inc. Systems and methods for treating back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
WO2014071161A1 (en) 2012-11-05 2014-05-08 Relievant Medsystems, Inc. System and methods for creating curved paths through bone and modulating nerves within the bone
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
AU2020346827A1 (en) 2019-09-12 2022-03-31 Relievant Medsystems, Inc. Systems and methods for tissue modulation
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
JP2024505335A (ja) 2020-12-22 2024-02-06 リリーバント メドシステムズ、インコーポレイテッド 脊椎神経調節の候補の予測
GB202305212D0 (en) * 2023-04-06 2023-05-24 Elixa Mediscience Ltd Compounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500620A (ja) * 1993-06-28 1997-01-21 アストラ・アクチエボラーグ 極小の運動遮断で鎮痛効果を示す医薬の製造におけるロピバカインの使用
JP2001522888A (ja) * 1997-11-19 2001-11-20 ダーウィン・ディスカバリー・リミテッド 麻酔用製剤
JP2004531543A (ja) * 2001-04-30 2004-10-14 トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル 医薬として活性なウリジンエステル
WO2009061497A1 (en) * 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US20120022147A1 (en) * 2011-08-17 2012-01-26 Krisani Biosciences (P) Ltd 2, 6 xylidine derivatives for the treatment of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187813A (zh) * 1995-05-01 1998-07-15 斯科舍集团有限公司 作为生物活性化合物的脂肪酸酯
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500620A (ja) * 1993-06-28 1997-01-21 アストラ・アクチエボラーグ 極小の運動遮断で鎮痛効果を示す医薬の製造におけるロピバカインの使用
JP2001522888A (ja) * 1997-11-19 2001-11-20 ダーウィン・ディスカバリー・リミテッド 麻酔用製剤
JP2004531543A (ja) * 2001-04-30 2004-10-14 トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル 医薬として活性なウリジンエステル
WO2009061497A1 (en) * 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US20120022147A1 (en) * 2011-08-17 2012-01-26 Krisani Biosciences (P) Ltd 2, 6 xylidine derivatives for the treatment of pain

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021152048A (ja) * 2016-12-26 2021-09-30 セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited 慢性疼痛の処置のための組成物及び方法
JP7283792B2 (ja) 2016-12-26 2023-05-30 セリックス バイオ プライヴェート リミテッド 慢性疼痛の処置のための組成物及び方法

Also Published As

Publication number Publication date
ZA201408055B (en) 2016-03-30
SG11201407323WA (en) 2014-12-30
CN105612155A (zh) 2016-05-25
WO2013168006A3 (en) 2016-09-01
AU2013257727B2 (en) 2016-04-28
WO2013168006A2 (en) 2013-11-14
EP2882745A2 (en) 2015-06-17
CA2873138A1 (en) 2013-11-14
AU2013257727A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
JP2016508956A (ja) 局所疼痛の治療のための組成物と治療法
JP2015521184A (ja) メタボリック症候群の治療のための組成物と治療法
JP6202287B2 (ja) 炎症性腸疾患の治療のための組成物及び方法
CN104583182A (zh) 用于治疗粘膜炎的组合物和方法
JP2015518855A5 (zh)
JP6698643B2 (ja) 多発性硬化症の治療のための組成物及び方法
WO2019150341A1 (en) Combination of an antimuscarinic or an anticholinergic agent and lipoic acid and uses thereof
JP2020100623A (ja) 炎症及び疼痛の治療のための組成物及び方法
WO2013175376A2 (en) Compositions and methods for the treatment of local pain
CN104364241A (zh) 抑制碳酸酐酶活性的组合物和方法
EP3761970A1 (en) Compositions and methods for the treatment of neurological diseases
CN110099681A (zh) 用于治疗口腔干燥症的组合物和方法
WO2014091384A2 (en) Compositions and methods for the treatment of mucositis
JP2015518854A5 (zh)
JP2015519333A5 (zh)
CN104350041A (zh) 用于治疗神经系统疾病的组合物和方法
JP2015527309A (ja) 中等度から重度の疼痛の治療のための組成物及び方法
RU2751770C2 (ru) Композиции и способы лечения синдрома раздраженного кишечника
RU2749188C2 (ru) Композиции и способы лечения желудочно-кишечных полипов
JP2015526385A (ja) てんかんの治療のための組成物及び方法
JP2015521174A (ja) 糖尿病の治療のための組成物および方法
JP2015533114A (ja) 神経疾患の治療のための組成物及び方法
JP6698669B2 (ja) 粘膜炎の治療のための組成物及び方法
JP2015519334A5 (zh)
JP2018532704A (ja) パーキンソン病の治療のための組成物及び方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160413

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160823

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170321